3. Pyronaridine‐artesunate (PY‐AS) versus artemether‐lumefantrine (AL): other reported outcomes.
Trial | Fever clearance time | Parasite clearance time | ||
PY‐AS | AL | PY‐AS | AL | |
Kayentao 2012 | Median 8.1 h (95% CI 8.0 to 8.1) | Median 8.1 h (95% CI 8.0 to 15.8) | Median 24.1 h (95% CI 24.0 to 24.1) | Median 24.2 h (95% CI 24.1 to 32.0) |
Roth 2018 | Median 1 day (1‐1) | Median 1 day (1‐1) | Median 1 day (1‐2) | Median 2 days (1‐2) |
Tshefu 2010 | Mean 13.6 h (SD 8.9) | Mean 14.8 h (SD 10.1) | 23.3 h (SD 8.8) | 26.5 h (10.1) |
Abbreviations: AL: artemether‐lumefantrine; PY‐AS: pyronaridine‐artesunate.